Bioventix (GB:BVXP) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bioventix PLC’s Chief Financial Officer, Bruce Hiscock, has increased his stake in the company by purchasing 24 ordinary shares at an average price of 3,822 pence per share through a dividend reinvestment plan. This acquisition brings his total beneficial interest to 1,113 shares, representing a modest 0.02% of the company’s issued share capital. Such insider transactions can often be a point of interest for investors looking for signals of confidence in the company’s future performance.
For further insights into GB:BVXP stock, check out TipRanks’ Stock Analysis page.